Close Menu

AMP v. USPTO

By Turna Ray
The American Civil Liberties Union and the Public Patent Foundation have decided to ask the Supreme Court to take up their case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes.

Adding large gene rearrangement analysis to Myriad's Comprehensive BRACAnalysis test could detect variants associated with increased risk for hereditary breast and ovarian cancer that occur more frequently in some populations and would otherwise be missed.

The higher court will consider whether two method patents held by Prometheus Laboratories claim natural phenomena and are therefore not patentable under the law.

Diagnostic developers and legal experts have been keeping a close watch on Prometheus since the Federal Circuit Court of Appeals' handling of diagnostic method patents in that case may impact the AMP v. USPTO gene-patenting lawsuit that is pending review by the same court.

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.